Organized in conjunction with the Hellenic Innovation Network and Massachusetts Institute of Technology Enterprise Forum Greece (MITEF), a trio of Foley & Lardner lawyers including David Kantaros (Partner, Boston), Kyle Faget (Partner, Boston), and Christopher McKenna (Partner, Boston) will be hosting an event in Athens to discuss cross-border expansion into the United States.
This event will focus on the process of raising capital, intellectual property considerations, and strategies for eliminating speed bumps to expanding operations into the U.S.
To learn more and register to attend, please click here.
Event Agenda
16:30 – 17:00: Arrival
17:00 – 19:00: General Session
- How to Structure Your Company to Raise funds and Expand Your Business Into the U.S. Markets
- Raising Capital in the U.S.: Typical financing offerings
- Intellectual Property Considerations: How to protect your IP and Investor / Buyer expectations
- Plan Early for Future Transactions with U.S. Buyers: Key steps companies should take beginning on Day 1 that will make future financings and the ultimately liquidity event a much smoother process
19:00 – 19:45: Breakout Sessions
- Breakout Session A: Roundtable discussion on current legal issues for software / technology companies
- Breakout Session B: Roundtable discussion on current legal issues for life science and health analytics companies
19:45 – 21:00: Reception/General Networking
People
Related Insights
30 August 2024
Viewpoints
FTC’s Ban on Noncompete Agreements Is Blocked
04 September 2024
Events
Navigating Intellectual Property While Building with AI
Foley Partner Eric Sophir will present on the topic of “Navigating Intellectual Property while building with AI” at the Martin Luther King Jr. Memorial Library on Wednesday, September 4, 2024, from 4:00 p.m.-5:00 p.m. EDT.
29 August 2024
Manufacturing Industry Advisor
2024 CPSC and FDA Enforcement Trends
The enforcement trends of 2023 have continued into 2024, especially with respect to the U.S. Consumer Product Safety Commission and the U.S. Food and Drug Administration.